Clinical Trial Update: Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety, tolerability and efficacy of ISIS-GCGRRx in adults with Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ISIS-GCGRRx

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED